Daré Bioscience cuts quorum threshold to one-third
Daré Bioscience’s board has lowered the quorum threshold for stockholder meetings from a majority of voting power to one-third.
Rhea-AI Filing Summary
Daré Bioscience, Inc. (DARE) reports that on September 10, 2026, its board of directors approved an amendment to the company’s Third Amended and Restated By-Laws to change the stockholder meeting quorum standard. The quorum requirement was reduced from holders of a majority in voting power of outstanding shares entitled to vote to holders of at least one-third of the voting power of such shares, effective immediately. The amendment text is provided as an exhibit and incorporated by reference.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
New quorum threshold: At least one-third of the voting power of outstanding shares entitled to vote
Prior quorum threshold: Majority in voting power of outstanding shares entitled to vote
By-law document referenced: Third Amended and Restated By-Laws, amended by Exhibit 3.1
3 metrics
New quorum threshold
At least one-third of the voting power of outstanding shares entitled to vote
Quorum requirement for all stockholder meetings after the by-law amendment approved September 10, 2026
Prior quorum threshold
Majority in voting power of outstanding shares entitled to vote
Previous quorum requirement for Daré Bioscience stockholder meetings before the amendment
By-law document referenced
Third Amended and Restated By-Laws, amended by Exhibit 3.1
Governing by-laws modified to change quorum requirement
Key Terms
quorum requirement, voting power, Third Amended and Restated By-Laws, emerging growth company
4 terms
quorum requirement regulatory
"to reduce the quorum requirement for all stockholder meetings of the Company"
voting power financial
"from the holders of a majority in voting power of the shares"
Voting power is the ability shareholders have to influence a company's major decisions—like electing the board, approving mergers, or changing corporate rules—based on the voting rights attached to the shares they hold. For investors it matters because greater voting power is like holding more keys to a building: it gives you a stronger say over management choices and the company’s strategy, which can affect future value and risk.
Third Amended and Restated By-Laws regulatory
"approved an amendment to the Third Amended and Restated By-Laws of the Company"
emerging growth company regulatory
"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What corporate change did Daré Bioscience (DARE) disclose in this 8-K?
Daré Bioscience disclosed that its board approved an amendment to the Third Amended and Restated By-Laws, effective September 10, 2026, reducing the quorum requirement for all stockholder meetings. The full text of the amendment is attached as Exhibit 3.1.
How did Daré Bioscience (DARE) change its quorum requirement for stockholder meetings?
The company changed its quorum standard from holders of a majority in voting power of outstanding shares entitled to vote at a meeting to holders of at least one-third of the voting power of such shares. This applies to all stockholder meetings.
When did the Daré Bioscience (DARE) bylaw amendment on quorum become effective?
The bylaw amendment became effective immediately upon approval by the board of directors on September 10, 2026, and governs quorum requirements for all stockholder meetings from that date forward.
Where can investors see the exact text of Daré Bioscience’s new quorum provision?
The exact text of the new quorum provision is included as Exhibit 3.1, titled “Amendment to Third Amended and Restated By-Laws of Daré Bioscience, Inc.,” and is incorporated by reference in the report.
Does this Daré Bioscience (DARE) filing involve any financing or earnings information?
No. The filing focuses on a corporate governance change: amending the by-laws to reduce the quorum requirement for stockholder meetings. It does not present earnings data, financing transactions, or changes to the company’s securities beyond this governance update.
What stock is referenced in Daré Bioscience’s (DARE) 8-K and where is it listed?
The filing references Daré Bioscience’s common stock, which is listed under the trading symbol DARE on the Nasdaq Capital Market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
